>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
糖尿病与阿尔茨海默病关系的研究进展
作者:王清1  谢春明2  张志珺2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 神经内科, 江苏 南京 210009
关键词:阿尔茨海默病 痴呆 糖尿病 文献综述 
分类号:R587.1;R749.16
出版年·卷·期(页码):2018·37·第三期(510-514)
摘要:

阿尔茨海默病(AD)是最常见的神经退行性疾病。随着人口的老龄化,AD患病率急剧升高,但有效治疗却是难题。因此,寻找影响AD的风险因素,探讨其影响AD的机制、早期识别AD高危人群、发现新的干预靶点已经成为AD研究领域的热点。现有研究表明,糖尿病和AD均与老龄化密切相关,并且发病率和患病率均随着年龄增长而升高。作者主要围绕糖尿病与AD的关系以及如何干预糖尿病的研究进展作一综述。

参考文献:

[1] KEITH F,LAURA B.Alzheimer's Association Report:2014 Alzheimer's disease facts and figures[J].Am St,2014,10(2):47-92.
[2] PRINCE M,GUERCHET M,PRINA M.The epidemiology and impact of dementia:current state and future trends[EB/OL].2015.Available online:http://www.who.int/en.
[3] PRINCE M,WIMO A,GUERCHET M,et al.World Alzheimer Report 2015:The global impact of dementia:an analysis of prevalence,incidence,cost and trends[EB/OL].2015.Available online:http://www.alz.co.uk.
[4] PRINCE M,KNAPP M,GUERCHET M,et al.World Alzheimer Report 2016:Improving healthcare for people living with dementia[EB/OL].2016.Available online:http://www.alz.co.uk.
[5] DOODY R,FARLOW M,AISEN P,et al.Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease[J].N Engl J Med,2014,370(15):1459-1460.
[6] BARBAGALLO M,DOMINGUEZ L J.Type 2 diabetes mellitus and Alzheimer's disease[J].World J Diabetes,2014,5(6):889-893.
[7] CHEN L,ZIMMET P.The worldwide epidemiology of type 2 diabetes mellitus-Present and future perspectives[J].Nat Rev Endocrinol,2012,8(4):228-236.
[8] ROBERTS R O,KNOPMAN D S,CHA R H,et al.Diabetes and Elevated HbA1c levels are Associated with Brain Hypometabolism but not Amyloid Accumulation[J].J Nucl Med,2014,55(5):759-764.
[9] LU F P,LIN K P,KUO H K.Diabetes and the risk of multi-system aging phenotypes:a systematic review and Meta-analysis[EB/OL].2009.Available online:www.plosone.org.
[10] GUDALA K,BANSAL D,SCHIFANO F,et al.Diabetes mellitus and risk of dementia:A meta-analysis of prospective observational studies[J].J Diabetes Investig,2013,4(6):640-650.
[11] FELICE F G,FERREIRA S T.Inflammation,defective insulin signaling,and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease[J].Diabetes,2014,63(7):2262-2272.
[12] GOLDWASER E L,ACHARYA N K,SARKAR A,et al.Breakdown of the cerebrovasculature and blood-brain barrier:a mechanistic link between diabetes mellitus and Alzheimer's disease[J].J Alzheimer Dis,2016,54(2):445-456.
[13] CHENG G,HUANG C,DENG H,et al.Diabetes as a risk factor for dementia and mild cognitive impairment:a meta-analysis of longitudinal studies[J].Intern Med J,2012,42(5):484-491.
[14] EDWARD W,GREGG P,JANE A,et al.Is diabetes associated with cognitive impairment and cognitive decline among older women?[J].Arch Intern Med,2000,160(1):74-80.
[15] OTT A,STOLK R P,van HARSKAMP F,et al.Diabetes mellitus and the risk of dementia:the Rotterdam Study[J].Neurology,1999,53(9):1937-1942.
[16] OTT A,STOLK R P,HOFMAN A,et al.Association of diabetes mellitus and dementia:the Rotterdam Study[J].Diabetologia,1996,39(11):1392-1397.
[17] BIESSELS G,STAEKENBORG S,BRUNNER E,et al.Risk of dementia in diabetes mellitus:a systematic review[J].Lancet Neurol,2006,5(1):64-74.
[18] PROFENNO L A,PORSTEINSSON A P,FARAONE S V.Meta-analysis of Alzheimer's disease risk with obesity,diabetes,and related disorders[J].Biol Psychiat,2010,67(6):505-512.
[19] JAGUST W,MUNGAS D,HAAN M.Central obesity and the aging brain[J].Arch Neurol,2005,62:1545-1548.
[20] FARRIS W,MANSOURIAN S,CHANG Y,et al.Insulin-degrading enzyme regulates the levels of insulin,amyloid beta-protein,and the beta-amyloid precursor protein intracellular domain in vivo[J].P Natl Acad Sci U S A,2003,100(7):4162-4167.
[21] YANG Y,SONG W.Molecular links between Alzheimer's disease and diabetes mellitus[J].Neuroscience,2013,250:140-150.
[22] PUGAZHENTHI S,QIN L,REDDY P H.Common neurodegenerative pathways in obesity,diabetes,and Alzheimer's disease[EB/OL].2016.Available online:www.elsevier.com/locate/bbadis.
[23] KLOPPENBORG R P,BERG E,KAPPELLE L J,et al.Diabetes and other vascular risk factors for dementia:which factor matters most? a systematic review[J].Eur J Pharmacol,2008,585(1):97-108.
[24] MCGEER P L,ROGERS J,MCGEER E G.Inflammation,antiinflammatory agents,and Alzheimer's disease:the last 22 years[J].J Alzheimer Dis,2016,54(3):853-857.
[25] RIBE E M,LOVESTONE S.Insulin signalling in Alzheimer's disease and diabetes:from epidemiology to molecular links[J].J Gen Intern Med,2016,280(5):430-442.
[26] NATALIA A,STEFANOVA N,EKATERINA A,et al.An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology[J].Aging,2016,8(11):2713-2733.
[27] HENQUIN J C,DUFRANE D,GMYR V,et al.A pharmacological approach to understanding the control of insulin secretion in human islets[J].Diabetes Obes Metab,2017,19(8):1061-1070.
[28] CHEN M,HU C,JIA W.Pharmacogenomics of glinides[J].Pharmacogenomics,2015,16(1):45-60.
[29] PIETROCOLA F,KROEMER G.Metformin:a metabolic modulator[J].Oncotarget,2017,8(6):9017-9020.
[30] YASMIN S,JAYAPRAKASH V.Thiazolidinediones and PPAR orchestra as antidiabetic agents:from past to present[J].Eur J Med Chem,2017,126:879-893.
[31] STANDL E,SCHNELL O.Alpha-glucosidase inhibitors 2012-cardiovascular considerations and trial evaluation[J].Diabetes Vasc Dis Re,2012,9(3):163-169.
[32] QASEEM A,BARRY M J,HUMPHREY L L,et al.Oral pharmacologic treatment of type 2 diabetes mellitus:a clinical practice guideline update from the American College of Physicians[J].Ann Intern Med,2017,166(4):279-290.
[33] THOMPSON P L,DAVIS T M.Cardiovascular effects of glucose-lowering therapies for type 2 diabetes:new drugs in perspective[J].Clin Ther,2017,39(5):1012-1025.
[34] MALINOWSKI J M,BOLESTA S.Rosiglitazone in the treatment of type 2 diabetes mellitus:a critical review[J].Clin Ther,2000,22(10):1151-1168.
[35] REGER M A,WATSON G S,GREEN P S,et al.Intranasal insulin improves cognition and modulates beta-amyloid in early AD[J].Neurology,2008,70(6):440-448.
[36] REGER M A,WATSON G S,BAKER L D,et al.Effects of intranasal insulin on cognition in memory-impaired older adults:modulation by APOE genotype[J].Neurobiol Aging,2006,27(3):451-458.
[37] DURING M J,CAO L,ZUZGA D S,et al.Glucagon-like peptide-1 receptor is involved in learning and neuroprotection[J].Nat Med,2003,9(9):1173-1179.
[38] ROLLAND Y,ABELLAN V,VELLAS B.Physical activity and Alzheimer's disease:from prevention to therapeutic perspectives[J].J Am Med Dir Assoc,2008,9(6):390-405.
[39] BLONDELL S J,HAMMERSLEY-MATHER R,VEERMAN J L.Does physical activity prevent cognitive decline and dementia?:a systematic review and meta-analysis of longitudinal studies[EB/OL].2014.Availableonline:https://www.biomedcentral.com.
[40] BEYDOUN M A,BEYDOUN H A,GAMALDO A A,et al.Epidemiologic studies of modifiable factors associated with cognition and dementia:systematic review and meta-analysis[EB/OL].2014.Available online:https://www.biomedcentral.com.
[41] DOUGHERTY R J,ELLINGSON L D,SCHULTZ S A,et al.Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease[EB/OL].2016.Available online:https://www.alz.co.uk.
[42] KIM M J,HAN C W,MIN K Y,et al.Physical exercise with multicomponent cognitive intervention for older adults with Alzheimer's disease:a 6-month randomized controlled trial[J].Dement Geriatr Cogn,2016,6(2):222-232.
[43] 余曙光,周奇志,张新如,等.针刺对老年痴呆模型大小鼠AchE活性影响的实验研究[J].针灸临床杂志,2002,18(9):43-45.
[44] 唐纯志,赖新生,林展弘,等.电针对老年性痴呆大鼠脑兴奋性氨基酸含量的影响[J].四川中医,2005,23(2):16-17.
[45] 包永欣,吕冠华.针刺对痴呆小鼠记忆障碍和单胺神经递质的影响[J].上海针灸杂志,2003,22(7):23-25.
[46] CAO Y,WANG J,DU S Q,et al.Mechanisms of acupuncture effect on Alzheimer's disease in animal-based researches[J].Curr Top Med Chem,2016,16(5):574-578.
[47] 卢圣峰,邵欣,唐勇,等.电针促进阿尔茨海默病模型小鼠_SAMP8_海马神经元突触可塑性的神经细胞黏附机制[J].中国康复医学杂志,2008,23(12):1057-1060.
[48] 张迪,孙丽英.电针-百会风府-穴对学习记忆障碍大鼠细胞凋亡的影响[J].辽宁中医杂志,2007,34(7):1006-1008.
[49] 贾成文,张敏,赵卫峰.补肾益髓-针灸法对痴呆模型大鼠CNS信息转导途径的影响[J].陕西中医学院学报,2005,28(6):38-41.
[50] 牛文民,刘志斌,杨晓航,等.嗅三针治疗对阿尔茨海默病模型大鼠海马蛋白激酶A活性的影响[J].中西医结合研究,2014,6(3):133-136.
[51] 朱书秀,孙国杰.电针对阿尔茨海默病模型大鼠学习记忆能力及海马区胶质细胞的影响[J].中国针灸,2009,29(2):133-136.
[52] REINIGER L,LUKIC A,LINEHAN J,et al.Tau,prions and Abeta:the triad of neurodegeneration[J].Acta Neuropathol,2011,121(1):5-20.
[53] 张忠,李志刚,薛卫国,等.电针"百会"、"涌泉"两穴对+APP_PS1双转基因小鼠学习记忆行为与海马超微结构的影响[J].环球中医药,2015,8(4):389-394.
[54] ZHOU J,PENG W,XU M,et al.The effectiveness and safety of acupuncture for patients with Alzheimer disease:a systematic review and meta-analysis of randomized controlled trials[EB/OL].2015.Availiable online:http://journals.lww.com/md-journal/pages/default.aspx.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412620 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364